Tilt Hldgs Inc Stock Price, News & Analysis

TILT Holdings Inc. announced the launch of the Infinity vaporizer, developed in collaboration with Jupiter Research and Commonwealth Alternative Care. Available starting May 20, 2022, at CAC locations and Massachusetts dispensaries, the Infinity features 300mg of cannabis extracts and utilizes CCELL® Heat-not-Burn technology. This product offers two strain options: Cinderella 99 and LA Kush Cake. The launch follows a successful previous collaboration in Pennsylvania, aiming to expand TILT’s market presence in the cannabis sector.

TILT Holdings Inc. reported its Q1 2022 financial results, with revenue of $42.4 million, down from $46.8 million year-over-year. Gross profit declined to $9.4 million, representing a margin of 22%. The company's operating expenses increased to $10.4 million, resulting in adjusted EBITDA of $1.5 million. TILT also announced two sale leaseback transactions totaling $55 million, aimed at reducing debt by up to 50%. Despite challenges in sales volume and inflationary pressures, the company expects 2022 revenue growth of approximately 28% and continues to forge strong partnerships in the cannabis sector.

TILT Holdings announced an exclusive partnership with Black Buddha Cannabis to launch its products in Massachusetts and later expand into Pennsylvania. Black Buddha Cannabis, founded by Roz McCarthy, focuses on wellness through its unique product lines like Black Buddha Prepacks™ and fast-acting gummies. The collaboration aims to enhance social equity and support local black farmers. With cannabis sales hitting $1.6B in Massachusetts last year, this initiative positions TILT to capitalize on growing market opportunities while promoting community engagement.

TILT Holdings Inc. (OTCQX: TLLTF), a leader in cannabis solutions, announced its participation in several upcoming investor conferences. Notable events include the Alliance Global Partners Spring Consumer Cannabis Conference on May 3, 2022, where management will engage in one-on-one meetings, and the Canaccord Genuity Cannabis Conference on May 11, 2022, featuring a presentation by CEO Gary Santo. Additionally, Santo will join a panel at the Wolfe Research Virtual Consumer Conference on May 13, 2022. For details on webcasts and presentations, visit TILT's investor relations website.

TILT Holdings Inc. will host a conference call on May 16, 2022, at 5:00 p.m. Eastern Time to discuss its Q1 2022 financial results. The call will provide an opportunity for management to present the results followed by a question-and-answer session. Interested participants are encouraged to dial in 10 minutes early. The earnings report will precede the call, which will also be available for replay on TILT's investor relations website. TILT operates in the cannabis sector, offering solutions across various markets.

TILT Holdings has filed a Registration Statement on Form 10 with the SEC to register its common shares under the Exchange Act. This filing aims to align TILT with U.S. reporting standards, enhancing transparency for shareholders. CEO Gary Santo highlighted the importance of this step towards growth and federal legalization. Upon effectiveness, TILT will adhere to Exchange Act reporting requirements, including financial results in U.S. GAAP. The Form 10 is also available on SEC's website and SEDAR.

TILT Holdings has announced its participation in major cannabis conferences in April 2022. CEO Gary Santo will speak at the Cantor Investor Conference on April 14 and the Benzinga Cannabis Capital Conference on April 20. The company will also hold one-on-one investor meetings at these events. Additionally, Santo will appear on the MJ Stock Trader Podcast on April 4 and Benzinga’s Cannabis Insider on April 7. TILT Holdings focuses on providing cannabis business solutions across various sectors, including cultivation and retail.

TILT Holdings reported strong financial results for Q4 and FY 2021, with revenues up 28% YoY to $54.1 million and $202.7 million, respectively. Adjusted EBITDA for Q4 increased to $4.8 million, while FY 2021 adjusted EBITDA rose 33% to $22.5 million. The company expanded its operations significantly, launching new dispensaries and increasing its cultivation capacity. However, gross margins declined due to higher freight costs and customer mix. Looking ahead, TILT anticipates 2022 revenues between $255-$265 million, marking potential growth despite external market pressures.